Heterologous Immune Responses of Serum IgG and Secretory IgA Against the Spike Protein of Endemic Coronaviruses During Severe COVID-19

被引:9
|
作者
Smit, Wouter L. [1 ,2 ]
van Tol, Sophie [3 ]
van der Wal, Sanne [1 ]
van Vulpen, Femke [1 ]
la Grouw, Shannon [1 ]
van Lelyveld, Lenneke [4 ]
Limonard, Gijs [5 ]
Bossink, Ailko [5 ]
Godeke, Gert-Jan [3 ]
Shrestha, Sandhya [3 ]
Reimerink, Johan [3 ]
Eggink, Dirk [3 ]
Reusken, Chantal [3 ]
Heron, Michiel [1 ]
Thijsen, Steven [1 ]
机构
[1] Diakonessenhuis Utrecht, Dept Med Microbiol & Immunol, Utrecht, Netherlands
[2] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands
[3] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands
[4] Diakonessenhuis Utrecht, Dept Intens Care, Utrecht, Netherlands
[5] Diakonessenhuis Utrecht, Dept Pulm Dis, Utrecht, Netherlands
来源
FRONTIERS IN IMMUNOLOGY | 2022年 / 13卷
关键词
SARS-CoV-2; COVID-19; spike protein; seasonal coronaviruses; immune imprinting; SARS-COV-2;
D O I
10.3389/fimmu.2022.839367
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Defining immune correlates of disease severity is important to better understand the immunopathogenesis in COVID-19. Here we made use of a protein microarray platform to detect IgG- and IgA-reactive antibodies in sera and saliva respectively, and assess cross-reactivity between SARS-CoV-2 and endemic coronaviruses (eCoVs). IgG responses against the full protein of spike, but not the S1 subunit, were significantly higher in convalescent sera of patients with severe disease compared to mild disease and healthy controls. In addition, we detected reactivity of secretory IgA to eCoVs in saliva of patients with severe disease, not present in patients with moderate disease or seropositive healthy controls. These heterologous immune responses are in line with non-protective cross-reactivity, and support a potential role for immune imprinting in the pathogenesis of severe COVID-19.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Comparison Of serum Anti-Spike (S) IgG Covid-19 Antibody between Breakthrough Infection And recent COVID-19 Infections in unvaccinated
    De, Sajal
    Sahu, Dibakar
    Mahilang, Diksha
    Bhargava, Anudita
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [42] Antibodies targeting conserved non-canonical antigens and endemic coronaviruses associate with favorable outcomes in severe COVID-19
    Peddireddy, Sai Preetham
    Rahman, Syed A.
    Cillo, Anthony R.
    Vijay, Godhev Manakkat
    Somasundaram, Ashwin
    Workman, Creg J.
    Bain, William
    McVerry, Bryan J.
    Methe, Barbara
    Lee, Janet S.
    Ray, Prabir
    Ray, Anuradha
    Bruno, Tullia C.
    Vignali, Dario A. A.
    Kitsios, Georgios D.
    Morris, Alison
    Singh, Harinder
    Sarkar, Aniruddh
    Das, Jishnu
    CELL REPORTS, 2022, 39 (13):
  • [43] Presence and strength of binding of IgM, IgG and IgA antibodies against SARS-CoV-2 during CoViD-19 infection
    Schasfoort, Richard B. M.
    van Weperen, Jos
    van Amsterdam, Margot
    Parisot, Judicael
    Hendriks, Jan
    Koerselman, Michelle
    Karperien, Marcel
    Mentink, Anouk
    Bennink, Martin
    Krabbe, Hans
    Terstappen, Leon W. M. M.
    Mulder, A. H. Leontine
    BIOSENSORS & BIOELECTRONICS, 2021, 183
  • [44] Towards robust immune responses after heterologous COVID-19 vaccination and its application perspectives
    Yong Lin
    Ailong Huang
    National Science Open, 2022, 1 (01) : 18 - 23
  • [45] Triple immune modulator therapy for aberrant hyperinflammatory responses in severe COVID-19
    Koh, June -Young
    Ko, Jae-Hoon
    Lim, So Yun
    Bae, Seongman
    Huh, Kyungmin
    Cho, Sun Young
    Kang, Cheol-In
    Chung, Doo Ryeon
    Chung, Chi Ryang
    Kim, Sung -Han
    Peck, Kyong Ran
    Lee, Jeong Seok
    CLINICAL IMMUNOLOGY, 2023, 251
  • [46] Humoral immune responses to COVID-19 vaccines are reduced in patients with severe asthma
    Rupani, H.
    Edwards, D.
    Chaudhuri, R.
    Smith, S.
    Jackson, D.
    Hearn, A.
    Richards, J.
    Moyses, H.
    Edwards, M.
    Johnston, S.
    Kurukularaaratchy, R.
    Haitchi, H. M.
    Djukanovic, R.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [47] Why COVID-19 is Less Frequent and Severe in Children: Understanding the Immune Responses
    Singh, Priyadarshini
    Vaishnav, Lokesh
    Joshi, Shiv
    Joshi, Abhishek
    Mehendale, Ashok
    JOURNAL OF RESEARCH IN MEDICAL AND DENTAL SCIENCE, 2022, 10 (10): : 145 - 150
  • [48] Metabolic programs define dysfunctional immune responses in severe COVID-19 patients
    Thompson, Elizabeth A.
    Cascino, Katherine
    Ordonez, Alvaro A.
    Zhou, Weiqiang
    Vaghasia, Ajay
    Hamacher-Brady, Anne
    Brady, Nathan R.
    Sun, Im-Hong
    Wang, Rulin
    Rosenberg, Avi Z.
    Delannoy, Michael
    Rothman, Richard
    Fenstermacher, Katherine
    Sauer, Lauren
    Shaw-Saliba, Kathyrn
    Bloch, Evan M.
    Redd, Andrew D.
    Tobian, Aaron A. R.
    Horton, Maureen
    Smith, Kellie
    Pekosz, Andrew
    D'Alessio, Franco R.
    Yegnasubramanian, Srinivasan
    Ji, Hongkai
    Cox, Andrea L.
    Powell, Jonathan D.
    CELL REPORTS, 2021, 34 (11):
  • [49] HUMORAL IMMUNE RESPONSES TO COVID-19 VACCINES ARE REDUCED IN PATIENTS WITH SEVERE ASTHMA
    Rupani, H.
    Edwards, D.
    Richards, J.
    Chaudhuri, R.
    Smith, S.
    Jackson, D. J.
    Hearn, A.
    Edwards, M.
    Johnston, S.
    Moyses, H.
    Kurukulaaratchy, R. J.
    Haitchi, H. M.
    Djukanovic, R.
    THORAX, 2022, 77 : A174 - A174
  • [50] Systematic evaluation of IgG responses to SARS-CoV-2 spike protein-derived peptides for monitoring COVID-19 patients
    Yang Li
    Dan-yun Lai
    Qing Lei
    Zhao-wei Xu
    Feng Wang
    Hongyan Hou
    Lingyun Chen
    Jiaoxiang Wu
    Yan Ren
    Ming-liang Ma
    Bo Zhang
    Hong Chen
    Caizheng Yu
    Jun-biao Xue
    Yun-xiao Zheng
    Xue-ning Wang
    He-wei Jiang
    Hai-nan Zhang
    Huan Qi
    Shu-juan Guo
    Yandi Zhang
    Xiaosong Lin
    Zongjie Yao
    Pengfei Pang
    Dawei Shi
    Wei Wang
    Xiao Yang
    Jie Zhou
    Huiming Sheng
    Ziyong Sun
    Hong Shan
    Xionglin Fan
    Sheng-ce Tao
    Cellular & Molecular Immunology, 2021, 18 : 621 - 631